|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
EXP |
Cilostazol results in decreased expression of MYC mRNA |
CTD |
PMID:19545562 |
|
NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
|
|
|
G |
HEXB |
hexosaminidase subunit beta |
multiple interactions increases secretion |
EXP |
G(M1) Ganglioside inhibits the reaction [Melitten results in increased secretion of HEXB protein]; sialogangliosides inhibits the reaction [Melitten results in increased secretion of HEXB protein]; trisialoganglioside GT1 inhibits the reaction [Melitten results in increased secretion of HEXB protein] |
CTD |
PMID:21334356 |
|
NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
|
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
increases expression multiple interactions |
EXP |
Niacinamide results in increased expression of PPARG protein Resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein] |
CTD |
PMID:22539994 |
|
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
increases acetylation multiple interactions decreases expression |
EXP |
Niacinamide results in increased acetylation of RUNX2 protein Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide results in increased acetylation of RUNX2 protein] |
CTD |
PMID:22539994 |
|
NCBI chr12:13,723,535...13,842,565
Ensembl chr12:13,628,539...13,840,785 Ensembl chr12:13,628,539...13,840,785
|
|
G |
SIRT1 |
sirtuin 1 |
decreases expression multiple interactions |
EXP |
Niacinamide results in decreased expression of SIRT1 protein Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of SIRT1 protein] |
CTD |
PMID:22539994 |
|
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression |
EXP |
Rifampin results in increased expression of ABCB1 mRNA; Rifampin results in increased expression of ABCB1 protein |
CTD |
PMID:22620706 |
|
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
increases activity |
EXP |
Rifampin results in increased activity of NR1I2 protein |
CTD |
PMID:27732639 |
|
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
|
|
|
G |
CPNE6 |
copine 6 |
decreases activity |
EXP |
Valproic Acid results in decreased activity of DHRS4 protein |
CTD |
PMID:17827741 |
|
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
|
|
|
G |
CNR2 |
cannabinoid receptor 2 |
affects binding |
EXP |
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone binds to CNR2 protein |
CTD |
PMID:21871882 |
|
NCBI chr 2:75,640,636...75,662,000
Ensembl chr 2:75,658,999...75,660,126
|
|